Identification of host and donor cells in porcine homograft heart valve explants by fluorescence in situ hybridization

Journal of Pathology

Volumn 183, Issue 1, 1997, Pages 99-104

  Braun, Jerry ^a   Hazekamp, Mark G ^a,b   Koolbergen, Dave R ^a   Sugihara, Hiroyuki ^b   Goffin, Yves A ^c   Huysmans, Hans A ^a   Cornelisse, Cees J ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c European Homograft Bank   (Belgium)

Author keywords

Animal studies; Aortic valve; Fluorescence in situ hybridization; Heart valve replacement; Homologous; Porcine studies; Transplantation; Y chromosome

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE REPLACEMENT; ARTICLE; DNA PROBE; EXPLANT; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT SURVIVAL; HEART VALVE; HOST CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; TRANSPLANTATION; X CHROMATIN;

ANIMALS; AORTIC VALVE; FEMALE; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; POSTOPERATIVE PERIOD; SWINE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; Y CHROMOSOME;

EID: 0030754349     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199709)183:1<99::AID-PATH1086>3.0.CO;2-L     Document Type: Article

References (23)

1. Penta A, Qureshi S, Radley-Smith R, Yacoub MH. Patient status 10 or more years after 'fresh' homograft replacement of the aortic valve. Circulation 1984; 70(Suppl 1): 182-186.
2. Angell WW, Angell JD, Oury JH, Lamberti JJ, Grehl TM. Long-term follow-up of viable frozen aortic homografts. A viable homograft valve bank. J Thorac Cardiovasc Surg 1987; 93: 815-822.
3. Barratt-Boyes BG, Roche AH, Subramanyan R, Pemberton JR, Whitlock RM. Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position. Circulation 1987; 75: 768-777.
4. Matsuki O, Rubles A, Gibbs S, Bodnar E, Ross DN. Long-term performance of 555 aortic homografts in the aortic position. Ann Thorac Surg 1988; 46: 187-191.
5. O'Brien MF, McGiffin DC, Stafford EG, et al. Allograft aortic valve replacement: long-term comparative clinical analysis of the viable cryopreserved and antibiotic 4°C stored valves. J Cardiac Surg 1991; 6(Suppl 4): 534-543.
6. Kirklin JK, Smith D, Novick W, et al. Long-term function of cryopreserved aortic homografts. A ten-year study. J Thorac Cardiovasc Surg 1993; 106: 154-166.
7. Gavin JB, Barratt-Boyes BG, Hitchcock GC, Herdson PB. Histopathology of 'fresh' human aortic valve allografts. Thorax 1973; 28: 482-487.
8. Gavin JB, Herdson PB, Monro JL, Barratt-Boyes BG. Pathology of antibiotic-treated human heart valve allografts. Thorax 1973; 28: 473-481.
9. Armiger LC, Gavin JB, Barratt-Boyes BG. Histological assessment of orthotopic aortic valve leaflet allografts: its role in selecting graft pre-treatment. Pathology 1983; 15: 67-73.
10. Hazekamp MG, Goffin YA, Huysmans HA. The value of the stentless biovalve prosthesis: an experimental study. Eur J Cardiothorac Surg 1993; 7: 514-519.
11. Hazekamp MG, Koolbergen DR, Braun J, et al. In situ hybridization: a new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants. J Thorac Cardiovasc Surg 1995; 110: 248-257.
12. Milan D, Yerle M, Schmitz A, et al. A PCR-based method to amplify DNA with random primers: determining the content of porcine flow-karyotype peaks by chromosome painting. Cytogenet Cell Genet 1993; 62: 139-141.
13. Yerle M, Schmitz A, Milan D, et al. Accurate characterization of porcine bivariate flow karyotype by PCR and fluorescence in situ hybridization. Genomics 1993; 16: 97-103.
14. Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2: 487.
15. Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964: 19: 131-150.
16. Mohri H, Reichenbach DD, Barnes RW, Merendino KA. Homologous aortic valve transplantation. Alterations in viable and nonviable valves. J Thorac Cardiovasc Surg 1968; 56: 767-774.
17. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, MeGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987; 94: 812-823.
18. Melo JQ, Monteiro C, Neves J, et al. The allograft heart valve in heart transplantation and valve replacement. Genetic assessment of the origin of the cells by means of deoxyribonucleic acid profiles. J Thorac Cardiovasc Surg 1995; 109: 218-222.
19. O'Brien MF, Johnston N, Stafford EG, et al. A study of the cells in the explanted viable cryopreserved allograft valve. J Cardiovasc Surg 1988: 3(Suppl): 279-287.
20. Allen MD, Shoji Y, Fujimura Y, et al. Growth and cell viability of aortic versus pulmonic homografts in the systemic circulation. Circulation 1991: 84(Suppl 1): 94-99.
21. Starzl TE, Trucco M, Zeevi A, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876-877.
22. Hrubnan RH, Long PP, Perlman EJ, Hutchins GM, Baumgartner KL, Griffin CA. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol 1993; 142: 975-980.
23. Kubit V, Sonmez-Alpan E, Zeevi A, et al. Mixed allogeneic chimerism in lung allograft recipients. Hum Pathol 1994; 25: 408-412.